AVAH
Aveanna HealthcareCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-18
Current thesis
The constructive case is that Aveanna is showing real operating momentum: FY2025 revenue rose to $2.433 billion from $2.025 billion, adjusted EBITDA rose to $320.9 million from $183.6 million, FY2026 guidance was maintained, and management is again pursuing tuck-in expansion through Family First.
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.5.
What can break
Family First integration and acquisition funding could reduce liquidity at close and create execution risk if expected synergies or growth do not materialize.
Momentum
41
Value
61
Sentiment
48
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $8.50 · Bull $11.00 · Bear $4.75
Data freshness
Prices
As of 2026-06-18
Fundamentals
As of 2026-06-15 • Vendor: Data Vendor v1
Scores
As of 2026-06-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-06 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-18
Investment thesis
As of 2026-06-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $11.00
Why
Momentum41 · Δ7d +8.4
Value61 · Δ7d -0.5
Sentiment48 · Δ7d -5.7
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
41
34% active weight
Current posture
7d trendImproving
Δ7d
+8.4
Δ21d
-23.2
Value
61
32% active weight
Current posture
7d trendFlat
Δ7d
-0.5
Δ21d
+0.2
Sentiment
48
33% active weight
Current posture
7d trendSoftening
Δ7d
-5.7
Δ21d
-4.9
Why this grade
Composite grade C. Momentum 41.2 / Value 61.5 / Sentiment 47.6
Fundamentals (TTM)As of 2026-06-15
Fundamentals (TTM)
As of 2026-06-15
Market Cap
$1.57B
Beta
2.06
Shares Out
208.91M
P/E (TTM)
22.4
P/S (TTM)
0.75
P/FCF (TTM)
20.81
Rev YoY
+22.2%
EPS YoY
+128.6%
Gross Margin
+33.6%
Op Margin
+9.8%
Net Debt
$1.37B
Current Ratio
1.23
As of 2026-06-18 • Updated nightlySource: Internal modelMethodology